Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05731375

Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage

Sponsor: UMC Utrecht

View on ClinicalTrials.gov

Summary

The goal of this observational study is to demonstrate the ability of using non-invasive Phosphorus (31P) Magnetic Resonance Spectroscopy (MRS) to monitor changes of in-vivo markers of mitochondrial function in skeletal and cardiac muscles in muscles in patients with cancer treated with anthracyclines and/or platinum-derivates. The main question it aims to answer is: • Can 31P-MRS be used to monitor changes of in vivo markers of mitochondrial function in skeletal and cardiac muscles in patients with cancer undergoing treatment with anthracyclines and or platinum derivates? To be able to answer this main question, participants will undergo 31P-MRS imaging of the calf muscles and of the heart 3 times during the study period.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

12

Start Date

2023-12-28

Completion Date

2026-03-20

Last Updated

2026-05-11

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

31-MRS at 7 Tesla (T)

31-MRS imaging at 7T to evaluate mitochondrial function in skeletal and cardiac muscles.

Locations (4)

Ziekenhuis Gelderse Vallei

Ede, Gelderland, Netherlands

Meander Medisch Centrum

Amersfoort, Utrecht, Netherlands

Diakonessenhuis

Utrecht, Utrecht, Netherlands

UMC Utrecht

Utrecht, Utrecht, Netherlands